» Articles » PMID: 35986688

The Microsomal Prostaglandin E Synthase-1/prostaglandin E2 Axis Induces Recovery from Ischaemia Via Recruitment of Regulatory T Cells

Abstract

Aims: Microsomal prostaglandin E synthase-1 (mPGES-1)/prostaglandin E2 (PGE2) induces angiogenesis through the prostaglandin E2 receptor (EP1-4). Among immune cells, regulatory T cells (Tregs), which inhibit immune responses, have been implicated in angiogenesis, and PGE2 is known to modulate the function and differentiation of Tregs. We hypothesized that mPGES-1/PGE2-EP signalling could contribute to recovery from ischaemic conditions by promoting the accumulation of Tregs.

Methods And Results: Wild-type (WT), mPGES-1-deficient (mPges-1-/-), and EP4 receptor-deficient (Ep4-/-) male mice, 6-8 weeks old, were used. Hindlimb ischaemia was induced by femoral artery ligation. Recovery from ischaemia was suppressed in mPges-1-/- mice and compared with WT mice. The number of accumulated forkhead box protein P3 (FoxP3)+ cells in ischaemic muscle tissue was decreased in mPges-1-/- mice compared with that in WT mice. Expression levels of transforming growth factor-β (TGF-β) and stromal cell derived factor-1 (SDF-1) in ischaemic tissue were also suppressed in mPges-1-/- mice. The number of accumulated FoxP3+ cells and blood flow recovery were suppressed when Tregs were depleted by injecting antibody against folate receptor 4 in WT mice but not in mPges-1-/- mice. Recovery from ischaemia was significantly suppressed in Ep4-/- mice compared with that in WT mice. Furthermore, mRNA levels of Foxp3 and Tgf-β were suppressed in Ep4-/- mice. Moreover, the number of accumulated FoxP3+ cells in ischaemic tissue was diminished in Ep4-/- mice compared with that in Ep4+/+ mice.

Conclusion: These findings suggested that mPGES-1/PGE2 induced neovascularization from ischaemia via EP4 by promoting the accumulation of Tregs. Highly selective EP4 agonists could be useful for the treatment of peripheral artery disease.

Citing Articles

Lipoteichoic Acid Rescued Age-Related Bone Loss by Enhancing Neuroendocrine and Growth Hormone Secretion Through TLR2/COX2/PGE2 Signalling Pathway.

Liu Z, Lin Z, Chen Y, Lu M, Hong W, Yu B J Cell Mol Med. 2024; 28(23):e70247.

PMID: 39622781 PMC: 11611525. DOI: 10.1111/jcmm.70247.


The Interplay between Medical Plants and Gut Microbiota in Cancer.

Caserta S, Genovese C, Cicero N, Toscano V, Gangemi S, Allegra A Nutrients. 2023; 15(15).

PMID: 37571264 PMC: 10421419. DOI: 10.3390/nu15153327.


Increased abundance of Ruminococcus gnavus in gut microbiota is associated with moyamoya disease and non-moyamoya intracranial large artery disease.

Mineharu Y, Nakamura Y, Sato N, Kamata T, Oichi Y, Fujitani T Sci Rep. 2022; 12(1):20244.

PMID: 36424438 PMC: 9691692. DOI: 10.1038/s41598-022-24496-9.

References
1.
Ohkura N, Hamaguchi M, Sakaguchi S . FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents. Trends Pharmacol Sci. 2011; 32(3):158-66. DOI: 10.1016/j.tips.2010.12.004. View

2.
Mahic M, Yaqub S, Johansson C, Tasken K, Aandahl E . FOXP3+CD4+CD25+ adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J Immunol. 2006; 177(1):246-54. DOI: 10.4049/jimmunol.177.1.246. View

3.
Takahashi R, Amano H, Ito Y, Eshima K, Satoh T, Iwamura M . Microsomal prostaglandin E synthase-1 promotes lung metastasis via SDF-1/CXCR4-mediated recruitment of CD11bGr1MDSCs from bone marrow. Biomed Pharmacother. 2019; 121:109581. DOI: 10.1016/j.biopha.2019.109581. View

4.
Gigante M, Gesualdo L, Ranieri E . TGF-beta: a master switch in tumor immunity. Curr Pharm Des. 2012; 18(27):4126-34. DOI: 10.2174/138161212802430378. View

5.
Amano H, Ito Y, Eshima K, Kato S, Ogawa F, Hosono K . Thromboxane A2 induces blood flow recovery via platelet adhesion to ischaemic regions. Cardiovasc Res. 2015; 107(4):509-21. DOI: 10.1093/cvr/cvv139. View